Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Rhode Island Hospital has 5 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 5 distinct examiners and 5 distinct art units. CORNELIUS, CLAIRE ADRIENNE is the busiest examiner, with 1 pending matter, so the pending prosecution activity is distributed across separate examination channels.
A centralized docket and claim-language review can support consistency across the biotechnology and pharmaceutical portfolio, but each response should be tailored to its examiner and art-unit record. Counsel should track technical evidence and specification support separately for every action. The absence of a repeated examiner assignment means that portfolio coordination should inform, rather than replace, application-specific prosecution decisions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (43%) |
| §103 only | 2 (29%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COOK, CHRISTOPHER L | 1 | 47.5% | +25.7% |
| CORNELIUS, CLAIRE ADRIENNE | 1 | 71.4% | +0.0% |
| BAYS, PAMELA M | 1 | 71.8% | +37.4% |
| YU, TIAN NMN | 1 | 55.6% | +19.3% |
| RAYMOND, KEITH MICHAEL | 1 | 55.5% | +21.5% |
| STAVROU, CONSTANTINA E | 1 | 42.4% | +35.6% |
| KIM, EUN HWA | 1 | 72.3% | +38.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19104034 | BONE SCAFFOLD WITH SONOLUCENT WINDOW | COOK, CHRISTOPHER L | — |
| 18708467 | PREDICTING COVID-19 ANTIBODIES AMONG SURVIVORS WITH DEEP RNA SEQUENCING | CORNELIUS, CLAIRE ADRIENNE | — |
| 18686786 | MRI-BASED PIPELINE TO EVALUATE RISK OF CONNECTIVE TISSUE REINJURY | BAYS, PAMELA M | — |
| 18528750 | USING DEEP RNA SEQUENCING DATA TO IDENTIFY ANTIMICROBIAL-RESISTANT BACTERIA | YU, TIAN NMN | — |
| 18314803 | CARTILAGE-DERIVED PROGENITOR CELL LINES | STAVROU, CONSTANTINA E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274279 | IMAGE-BASED APPROACH TO EVALUATE CONNECTIVE TISSUE STRUCTURE, REMODELING, AND RISK OF INJURY | RAYMOND, KEITH MICHAEL | 14d |
| 17997329 | SHAPE-MEMORY ALLOY AND POLYMER ELECTRODE ARRAY FOR MINIMALLY-INVASIVE SPINAL CORD AND BRAIN STIMULATION AND RECORDING | KIM, EUN HWA | 30d |
| 19104034 | BONE SCAFFOLD WITH SONOLUCENT WINDOW | COOK, CHRISTOPHER L | — |
| 18686786 | MRI-BASED PIPELINE TO EVALUATE RISK OF CONNECTIVE TISSUE REINJURY | BAYS, PAMELA M | — |
| 18528750 | USING DEEP RNA SEQUENCING DATA TO IDENTIFY ANTIMICROBIAL-RESISTANT BACTERIA | YU, TIAN NMN | — |
| 18314803 | CARTILAGE-DERIVED PROGENITOR CELL LINES | STAVROU, CONSTANTINA E | — |
| Art Unit | Apps |
|---|---|
| 3793 | 1 |
| 1672 | 1 |
| 3796 | 1 |
| 1681 | 1 |
| 3798 | 1 |
| 1632 | 1 |
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19104034 | BONE SCAFFOLD WITH SONOLUCENT WINDOW | COOK, CHRISTOPHER L | 3793 | §102§103 | Non-Final OA | — | Pending | Feb 14, 2025 |
| 18708467 | PREDICTING COVID-19 ANTIBODIES AMONG SURVIVORS WITH DEEP RNA SEQUENCING | CORNELIUS, CLAIRE ADRIENNE | 1672 | §101§102§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18686786 | MRI-BASED PIPELINE TO EVALUATE RISK OF CONNECTIVE TISSUE REINJURY | BAYS, PAMELA M | 3796 | §101§102§103 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18528750 | USING DEEP RNA SEQUENCING DATA TO IDENTIFY ANTIMICROBIAL-RESISTANT BACTERIA | YU, TIAN NMN | 1681 | §101§103§112 | Final Rejection | — | Pending | Dec 04, 2023 |
| 18274279 | IMAGE-BASED APPROACH TO EVALUATE CONNECTIVE TISSUE STRUCTURE, REMODELING, AND RISK OF INJURY | RAYMOND, KEITH MICHAEL | 3798 | §103 | Final Rejection | 14d | Pending | Jul 26, 2023 |
| 18314803 | CARTILAGE-DERIVED PROGENITOR CELL LINES | STAVROU, CONSTANTINA E | 1632 | §102§103 | Final Rejection | — | Pending | May 09, 2023 |
| 17997329 | SHAPE-MEMORY ALLOY AND POLYMER ELECTRODE ARRAY FOR MINIMALLY-INVASIVE SPINAL CORD AND BRAIN STIMULATION AND RECORDING | KIM, EUN HWA | 3794 | §103 | Non-Final OA | 30d | Pending | Oct 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRhode Island Hospital has 7 pending office actions as of October 2026, spread across 7 art units and 7 examiners.
Christopher L Cook has the most, with 1 of Rhode Island Hospital's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
